- Home
- VRA vs ABOS Comparison
VRA vs ABOS Comparison
Compare VRA & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- ABOS
- Stock Information
- Founded
- VRA 1982
- ABOS 1996
- Country
- VRA United States
- ABOS United States
- Employees
- VRA N/A
- ABOS N/A
- Industry
- VRA Apparel
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- ABOS Health Care
- Exchange
- VRA Nasdaq
- ABOS Nasdaq
- Market Cap
- VRA 162.4M
- ABOS 166.4M
- IPO Year
- VRA 2010
- ABOS 2021
- Fundamental
- Price
- VRA $5.38
- ABOS $2.50
- Analyst Decision
- VRA Strong Buy
- ABOS Strong Buy
- Analyst Count
- VRA 1
- ABOS 4
- Target Price
- VRA $6.00
- ABOS $9.00
- AVG Volume (30 Days)
- VRA 680.8K
- ABOS 167.9K
- Earning Date
- VRA 09-11-2024
- ABOS 11-11-2024
- Dividend Yield
- VRA N/A
- ABOS N/A
- EPS Growth
- VRA N/A
- ABOS N/A
- EPS
- VRA 0.02
- ABOS N/A
- Revenue
- VRA $439,677,000.00
- ABOS N/A
- Revenue This Year
- VRA $0.38
- ABOS N/A
- Revenue Next Year
- VRA $6.24
- ABOS N/A
- P/E Ratio
- VRA $221.35
- ABOS N/A
- Revenue Growth
- VRA N/A
- ABOS N/A
- 52 Week Low
- VRA $4.38
- ABOS $1.81
- 52 Week High
- VRA $8.35
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- VRA 47.07
- ABOS 46.15
- Support Level
- VRA $4.82
- ABOS $2.44
- Resistance Level
- VRA $5.50
- ABOS $2.66
- Average True Range (ATR)
- VRA 0.24
- ABOS 0.15
- MACD
- VRA 0.05
- ABOS 0.01
- Stochastic Oscillator
- VRA 73.53
- ABOS 52.96
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.